Introduction
The early development of mammalian craniofacial structures such as jaws, secondary palate and teeth is controlled by reciprocal interactions between ectodermal epithelium and neural crest-derived mesenchyme. These interactions are tightly controlled and involve dynamic changes in expression patterns of signaling molecules, growth factors and their receptors, and transcription factors (reviewed in Chai and Maxson, 2006) . The developing mouse tooth is a widely used system to investigate the functions of individual genes in this process and has been highly informative to define the molecular networks that control different steps during tooth morphogenesis (Pispa and Thesleff, 2003; Tucker and Sharpe, 2004) . Several homologous genes are expressed in overlapping patterns during tooth morphogenesis and their simultaneous inactivation often results in a more severe phenotype when compared to that of the single gene knockout mice. For example, consistent with functional redundancy among closely related transcription factors, double mutants lacking either Msx1 and Msx2, Dlx1 and Dlx2, Lhx6 and Lhx7, or Gli2 and Gli3 exhibit phenotypes that occur earlier or that are enhanced in severity relative to those in the respective single mutants (Bei and Maas, 1998; Thomas et al., 1997; Denaxa et al., 2009; Hardcastle et al., 1998) . In contrast, it is unknown to what extent genes encoding transcription factors that belong to different classes and that recognize different DNA sequences functionally interact during craniofacial and tooth development.
Pax9 and Msx1 encode transcription factors with different DNA binding motifs, a paired domain and a homeodomain, respectively, and are co-expressed during mouse craniofacial and tooth development (Mackenzie et al., 1991; Neubuser et al., 1995) . Targeted gene inactivation of each gene in mice has shown that both genes are essential for tooth and secondary palate development (Satokata and Maas, 1994; Peters et al., 1998) . In homozygous Pax9 or Msx1 mutants, all teeth fail to form and morphogenesis of the first molar, which has been examined in most detail, arrests after the dental epithelium has formed a bud. At this stage, both genes are necessary to maintain the mesenchymal expression of Bmp4 (Chen et al., 1996; Peters et al., 1998) , which is required for progression of the molar rudiment from the bud stage to the cap stage (Jernvall et al., 1998; Bei et al., 2000) . In addition, heterozygous mutations in human MSX1 or PAX9 underlie dominantly inherited oligodontia (congenital absence of at least six permanent teeth, excluding third molars), and are infrequently associated with missing primary teeth and orofacial clefting (Vastardis et al., 1996; Stockton et al., 2000 ; for recent reviews see Vieira, 2008; Nieminen, 2009) . In contrast to humans, heterozygous Pax9 or Msx1 loss-of-function mutations in mice do not affect secondary palate and tooth development, indicating that different gene dosages are required in the two species. In support of this, a reduction of functional Pax9 gene dosage to levels below heterozygosity is associated with oligodontia as the predominant phenotype in a Pax9 hypomorphic mouse model (Kist et al., 2005) .
In this study, we provide genetic evidence for a critical interaction between Pax9 and Msx1 in craniofacial and lower incisor development. Whereas cleft lip formation is incompletely penetrant in Pax9 ;Msx1 +/− double heterozygous mice. Our data demonstrate that the concomitant reduction of Pax9 and Msx1 gene dosages affect lower incisor development during initiation, morphogenesis and differentiation, and these processes are sensitive to Bmp4 gene dosage. Moreover, the regulation of Fgf3 and Fgf10 expression in the dental papilla of lower incisors is one critical downstream function of combined Pax9 and Msx1 function that controls the normal growth of these teeth.
Materials and methods

Mouse mutants and phenotype analysis
Generation and genotyping of Pax9 and Msx1 knockout mice have been described previously (Peters et al., 1998; Satokata and Maas, 1994) . Three different genetic backgrounds were used in this study. First, for scoring of cleft lip and skull abnormalities, transgenic rescue experiments and whole-mount in situ hybridization, we crossed BMP4 transgenic mice , which were on a mixed C57BL/6J;CBA/J genetic background, to Pax9/Msx1 double heterozygous mice to generate triple mutants with a mixed C57BL/6J;CBA/J; CD1 genetic background. Second, for histological analysis and gene expression studies on sections, Pax9/Msx1 double heterozygous mice on a CD1 background (NN10) or on a mixed C57BL/6;FVB;BALB/c background were used. In both genetic backgrounds the phenotype of missing incisors was fully penetrant. Mice on a mixed C57BL/6;FVB; BALB/c background were also used for BrdU incorporation and apoptosis assays. Staging of embryos was done by taking the morning of vaginal plug detection as embryonic day 0.5 (E0.5). A careful staging of embryos between E12.0 and E12.5 used for whole-mount RNA in situ hybridization was carried out by comparing the number of Shh-positive mystacial vibrissae rudiments, which develop in a highly coordinated caudo-rostral pattern between E12.0 and E13.5 (Van Exan and Hardy, 1984) . Heterozygous and homozygous mutants carrying the BMP4 transgene, which was previously shown to partially rescue early molar development of Msx1 homozygous mutant embryos were distinguished by DNA dot-blot analysis as previously described . Skeletal elements were stained using Alcian Blue for cartilage and Alizarin Red for bone (Peters et al., 1998) . For histological analysis, tissues were fixed with 4% paraformaldehyde, followed by standard paraffin embedding, sectioning, and hematoxylin and eosin staining.
RNA in situ hybridization and Pax9 immunostaining
RNA in situ hybridization on whole-mounts was performed as previously described (Sporle and Schughart, 1998) . Non-radioactive, mouse antisense RNA probes were generated using 640 bp Shh, 240 bp Bmp2, 1550 bp Bmp4, 1300 bp Fgf3, 580 bp Fgf10 and 625 bp p21 fragments (Nakatomi et al., 2006 ; details available upon request), respectively, by in vitro transcription labeling with digoxigenin-UTP according to the manufacturer's protocol (Roche, IN, USA). In addition, mRNA riboprobes for mouse Ameloblastin, Follistatin, Lef1, Msx1, Notch1, Pax9, p21, Runx2, Wnt-5a, and rat Shh for in situ hybridization on sections only were used as described (Aberg et al., 2004; . Detection of Pax9 protein on paraffin sections using a rat monoclonal anti-Pax9 antibody and Fast Red as a color substrate was performed as described previously (Gerber et al., 2002) .
Cell proliferation assay and TUNEL staining
Timed pregnant mice were injected intraperitoneally with 1 ml/ 100 g body weight of BrdU solution according to the manufacturer's protocol (Invitrogen, CA, USA). After 2 h, mouse heads were dissected and fixed in 4% PFA/PBS, processed for paraffin sections (7 µm), and BrdU incorporated cells were detected using a BrdU detection kit (Invitrogen, CA, USA). Images of every second section from the center of incisor teeth to the periphery were photographed, and five sections were counted for each tooth from three different mice of each genotype. A BrdU index was calculated by counting BrdU incorporated cells divided by total cells (ascertained as hematoxylin-stained nuclei). 
Results
Pax9 and Msx1 interact synergistically during upper lip development
The overlapping craniofacial expression patterns of Msx1 and Pax9, the ability of their gene products to interact in vitro, and the similarities of dental abnormalities in humans and mice caused by mutations in MSX1 (Msx1) and PAX9 (Pax9) suggested that these genes might interact in vivo. To test this hypothesis, we first generated Pax9 line; data not shown). Thus, combined Pax9 and Msx1 nullizygosity leads to a cleft lip phenotype that results from a genetic interaction between these loci. Whereas this result identified an important interaction between Pax9 and Msx1 in upper lip development, skeletal staining of single and relevant compound mutant mice showed that abnormalities in the skull and jaws represent a combination of the defects seen in the single mutants. In addition to a cleft secondary palate (Figs. 2B, C, G, H, and I), the predominant phenotype caused by absence of Pax9 alone is an absence of the palatal processes in the posterior part of the premaxilla (Figs. 2B, C, and I), whereas an anterior shortening of the premaxilla due to a missing nasal process results from absence of Msx1 (Figs. 2 G-I) . In addition, due to the absence of teeth in all mutants, the alveolar bones are missing in all mutants. In the lower jaw, absence of the coronoid process is caused by absence of Pax9 (Figs Since Msx1 and Pax9 are each required for the expression of Bmp4 in dental mesenchyme during early tooth formation (Chen et al., 1996; Peters et al., 1998) , we examined if the formation of affected teeth could be rescued by transgenic expression of Bmp4. This transgene, a human BMP4 cDNA, is expressed in the dental mesenchyme and analysis of adult Pax9 tg/tg mice when these mutations were kept on a pure ;Msx1 +/− mutants and a tissue resembling bone marrow was observed instead. (L) In rescued lower incisors, the thickness of the dentin layer is reduced, and ameloblasts and enamel are missing. The dentin is connected to bone by a periodontal ligament, which is normally present only on the enamel-free lingual side. ab, alveolar bone; am, ameloblasts; de, dentin; en, enamel; od, odontoblasts; pl, periodontal ligament; pm, periodontal mesenchyme.
CD1 background, indicating that the activity of the BMP4 transgene is suppressed in this genetic background. Consistent with a significant influence of the genetic background on lower incisor development, we observed that Msx1 +/− ;Pax9 +/− mutants on a mixed C57BL/ 6 × BALB/c background exhibited hypoplastic incisors, which erupted into the oral cavity but were chalky white and fragile, with hypoplastic cervical loops (data not shown).
Pax9
+/− ;Msx1 +/− mutants form a small dental papilla and exhibit severe growth defects of the lower incisor epithelium
To determine at which stage lower incisor primordia in Pax9
+/− mutants were morphologically affected, we carried out a histological analysis between the early bud (E12.5) and the bell (E15.5) stages (Figs. 4A-H). This analysis revealed that the dental papilla of Pax9 +/− ;Msx1 +/− mutant lower incisor primordia is significantly smaller at E13.5 (Fig. 4F) . At E14.5, the mutant lower incisors had progressed to the cap stage, but there was a pronounced epithelial growth defect affecting both upper (lingual) and lower (labial) incisor cervical loops, and a distinct enamel knot was not recognizable (Fig. 4G ). At E15.5, wild type incisor germs attain the bell stage and a mesenchymal condensation is present next to each cervical loop (arrows in Fig. 4D ). In contrast, in Pax9
mutants the paired condensations were absent and a single, mesenchymal protrusion developed instead that extended from the growth-retarded epithelium (Fig. 4H ). In addition, whereas wild type incisor growth is asymmetric, with the labial aspect longer than the lingual (Fig. 4D) 5C ) and, subsequently, is mainly associated with the mesenchyme adjacent to the upper and lower cervical loops (Fig. 5E ). In contrast, Msx1 transcripts are abundant throughout the dental mesenchyme at E13.5 (Fig. 5I) , and high expression levels persist in the distal compartment of the dental papilla (Fig. 5K) and McMahon, 1998; Jernvall et al., 1998; Cobourne et al., 2001; GritliLinde et al., 2002) . Collectively, the expression domains of these markers are laterally truncated in Pax9 +/− ;Msx1 +/− mutant lower incisors (Figs. 6B, H, and J). Among these markers, Bmp2 expression appeared to be most sensitive to Pax9;Msx1 double heterozygosity, and was absent at E12.5 (Fig. 6D) . Although Shh is expressed adjacent to the prospective incisor epithelium itself at the early bud stage (inset in Fig. 6I ), the reduction of Shh expression also affected the lateral domains ( ;BMP4 tg/tg triple mutants (Fig. 6N) , consistent with a previously demonstrated role of Bmp4 in inducing Shh expression during early tooth development .
Growth retardation of Pax9
+/− ;Msx1 +/− lower incisors is associated with a loss of mesenchymal Fgf3 and Fgf10 expression in the dental papilla
To investigate potential molecular causes for the lower incisor growth defects we analyzed the expression of Bmp4, Fgf3 and Fgf10 (Figs. 7A-X) , which encode growth factors with important roles during incisor morphogenesis and differentiation (Harada et al., 2002; Wang et al., 2007) . In addition, between E12.5 and E15.5, these genes exhibit expression domains similar to those of Pax9 and Msx1 in the dental mesenchyme. A reduced size of the Bmp4 expression domain was detected in Pax9 +/− ;Msx1 +/− mutant lower incisors at E12.5 and E13.5, while an ectopic expression domain in the mesenchyme separating the incisor and vestibular lamina was detected at E12.5 (Figs. 7B and D) . At E14.5, Bmp4 is also normally expressed in the enamel knot (Fig. 7E ) and this domain was either missing (Fig. 7F) ;Msx1 +/− mutants (Suppl. Fig. 2 ). In addition, the mesenchymal expression domain of Bmp4 in the mutants was significantly smaller compared to that of wild type lower incisors. At E15.5, two domains of up-regulated Bmp4 expression that normally exist adjacent to the growing tips of the dental epithelium (Fig. 7G) were lacking in Pax9 +/− ;Msx1 +/− mutants. Instead, Bmp4 was expressed in a domain that overlapped with the mesenchymal protrusion ( Fig. 7H ; compare Fig. 4H ). However, in contrast to earlier stages, at E15.5 Bmp4 appeared to be expressed in Pax9 +/− ;Msx1 +/− mutant incisor mesenchyme at levels similar to those in wild type incisors. In contrast to the transient down-regulation observed for Bmp4, the expression of Fgf3 was strongly affected in the mutants at all stages and was down-regulated to undetectable levels from E14.5 onwards (Figs. 7J , L, N and P). Similar to Fgf3, mesenchymal Fgf10 expression was absent in Pax9 +/− ;Msx1 +/− mutants at E14.5
( Fig. 7V) . At E15.5, the strong mesenchymal expression of Fgf10 that is normally present adjacent to the cervical loops (Fig. 7W ) was absent in Pax9 +/− ;Msx1 +/− mutants (Fig. 7X ). In contrast, there was no significant difference in the expression levels of Wnt5a, Runx2 and Lef1 in Pax9 +/− ;Msx1 +/− mutant incisor mesenchyme (Suppl. Fig. 2 ).
Moreover, expression levels of Fgf3 and Fgf10 during upper incisor and molar development were indistinguishable from those in control embryos (data not shown). Previous studies have shown that the mitogenic activities of Fgf3 and Fgf10 stimulate epithelial growth during tooth morphogenesis (Harada et al., 2002; Wang et al., 2007) ; we therefore hypothesized that the severely reduced expression of Fgf3 and Fgf10 in Pax9 +/− ; Msx1 +/− lower incisors might affect cell proliferation. To test this hypothesis, we carried out BrdU labeling assays (Figs. 8A-D, I ). At E13.5, the BrdU index was reduced by 35 ± 5% (mean ± SEM, p b 0.001) in the mutant dental epithelium, and by 23 ± 1% (p b 0.002) in the mutant dental mesenchyme (Figs. 8A, B , and I). At 14.5, the BrdU index was reduced by 25 ± 2% (p b 0.05) in the mutant dental epithelium and by 24 ± 2% (p b 0.01) in the mutant dental mesenchyme (Figs Incisor growth and differentiation in rodents is asymmetric, with the labial cervical loop longer than the lingual and responsible for generating functional ameloblasts (Fig. 9A) . Pax9 +/− ;Msx1 +/− mutant lower incisors, though severely hypoplastic, appeared symmetric and exhibited almost equivalent growth of both labial and lingual cervical loops (Fig. 9B ). This symmetric growth was maintained at least until E18.5 and, in a C57BL/6;FVB;BALB/c genetic background was characterized by columnar ameloblasts on both sides of the Pax9 +/− ;Msx1 +/− mutant incisors (Fig. 9B) . The ectopic presence of functional ameloblasts at the lingual aspect of Pax9 +/− ;Msx1 +/− mutant incisors was supported by the symmetric expression pattern of Ameloblastin (Fig. 9D) . Normally, in E16.5 wild type incisors, Follistatin transcripts are down-regulated in differentiating ameloblasts on the labial side, while expression remains in the undifferentiated inner dental epithelium on the lingual side ( Fig. 9E ; Wang et al., 2004) . In contrast, in Pax9 +/− ;Msx1 +/− mutants, Follistatin expression was down-regulated in both labial and lingual side dental epithelium, with only a thin layer of dental epithelium near the cervical loop regions retaining some follistatin transcripts (Fig. 9F) . A partial loss of lower incisor symmetry was indicated as early as E14.5, when the lingual epithelium of Pax9 +/− ;Msx1 +/− mutants exhibited Shh expression (Fig. 9H) , whereas Shh is predominantly expressed in labial epithelium in wildtype incisors (Fig. 9G) . Moreover, the symmetry defect in Pax9 ) had normal lower incisors (data not shown).
Discussion
Previous work has shown that Pax9 and Msx1 are key regulators of tooth development, as Pax9 or Msx1 nullizygosity in mice results in a loss of the odontogenic potential of the dental mesenchyme and an arrest of tooth formation at the bud stage (Satokata and Maas, 1994; Peters et al., 1998) . A drastic reduction of Pax9 gene dosage below that of Pax9 heterozygosity is associated with missing teeth, with lower incisors and third molars being the most susceptible tooth types (Kist et al., 2005) . Here we showed that the same tooth types are affected in mice with concomitant heterozygosity of Pax9 and Msx1 and that the lower incisor defects involve altered gene expression patterns shortly after initiation, severe growth retardation during morphogenesis, and a loss of asymmetry during differentiation. These results therefore not only indicate a critical genetic interaction between Pax9 and Msx1 in tooth development, but also identify previously unknown functions of both genes at several different stages of odontogenesis.
Expression changes of epithelial markers are associated with early size reduction of Pax9
The dental lamina is specified at E11.5 of mouse embryogenesis and expression of epithelial markers such as Bmp2, Shh and p21 subsequently identifies the sites of developing first molars and incisors (Dassule and McMahon, 1998; Cobourne et al., 2001 lower incisors, we found that these domains are either small or missing at E12.25 and E12.5, respectively. Thus, alterations in Pax9 and Msx1 gene dosage influence the size of tooth primordia during initiation. Since Pax9 and Msx1 are co-expressed in dental mesenchyme, their interaction must therefore, directly or indirectly, affect the expression and/or activity of secreted factors that control the correct size and duration of a molecular response in the adjacent dental epithelium. Several lines of evidence suggest that this control, at least in part, is mediated by the expression dependency of Bmp4 on Pax9 and Msx1. First, the expression of Bmp4 shifts from the epithelium to the mesenchyme at E11.5 and this expression is gradually lost in the developing molars of Pax9 or Msx1 single homozygous mutants (Vainio et al., 1993; Peters et al., 1998; Chen et al., 1996) . Second, Bmp4 is sufficient to induce Shh expression in the epithelium of Msx1-deficient tooth rudiments Zhao et al., 2000) . Third, a synergistic, Pax9/Msx1-mediated in vitro activation of transcription from the basal Bmp4 promoter was identified in a non-dental cell line (Ogawa et al., 2006) . Finally, the lateral truncation of Shh expression domains in Pax9 +/− ;Msx1 +/− mutant lower incisors was partially rescued by transgenic BMP4 expression as early as E12.25 (Fig. 2) . Whereas we identified slightly reduced expression domains of Bmp4 at E12.5 and E13.5 (Fig. 7) , whole-mount in situ hybridization of Bmp4 in Pax9 +/− ;Msx1 +/− mutant lower incisors failed to detect a laterally truncated domain of mesenchymal Bmp4 expression prior to E12.25. However, in addition to the limited sensitivity of this method to quantify small expression changes, we cannot rule out that the Pax9/ Msx1 interaction in the dental mesenchyme may also affect other aspects of the Bmp4 pathway. For example, a Pax9/Msx1 interaction may be required to indirectly regulate Bmp4 protein stability or its efficient diffusion, both of which providing possible explanations for a spatially restricted response to Bmp4 signaling in the lower incisor epithelium of Pax9 +/− ;Msx1 +/− mutants.
Growth defects of Pax9
+/− ;Msx1 +/− mutant lower incisors involve loss of Fgf3 and Fgf10 expression in the dental papilla Based on morphological criteria, the first recognizable defect of the Pax9 +/− ;Msx1 +/− lower incisor papilla is its reduced size at E13.5, a defect that is preceded by a smaller expression domain of Bmp4 and by an absence of Fgf3 expression in the dental mesenchyme at E12.5. Whereas in the mutants Fgf3 was weakly expressed at E13.5, Fgf3 expression was not detectable from E14.5 onwards and Fgf10 expression was strongly reduced at all stages analyzed. Fgf3 and Fgf10 have redundant functions during tooth development and not only regulate the proliferation of the mesenchymal cells of the dental papilla, but also act as mitogens in epithelial stem cells and transient amplifying (TA) cells in the lower incisor cervical loop (Harada et al., 2002; Wang et al., 2007) . Consistent with these functions, lower incisor development is strongly affected in Fgf3 −/− ;Fgf10 +/− compound mutant mice, whereas molars are less affected (Wang et al., 2007) . In addition, recent work has identified important roles of FGF3 and FGF10 in the regulation of tooth size in humans (Tekin et al., 2007; Alsmadi et al., 2009; Milunsky et al., 2006; Shams et al., 2007) . We thus conclude that the down-regulation of Fgf3 and Fgf10 expression in Pax9 +/− ;Msx1 +/− mutants is likely to be a major cause of the reduced cell proliferation and lower incisor growth defects.
Loss of lower incisor asymmetry
The specific growth rates and differentiation pathways of labial and lingual dental epithelia are key features of the continuously growing are presented for each developmental stage. Ek, enamel knot; lcl, lower cervical loop; tb, tooth bud; to, tongue; ucl, upper cervical loop; vl, vestibular lamina; wt, wild type. rodent incisors. Whereas the labial cervical loop is large and generates enamel-secreting ameloblasts, the lingual cervical loop is small and does not produce functional ameloblasts. This asymmetry is controlled by a complex regulatory network involving the Follistatin-mediated inhibition of ameloblast differentiation at the lingual aspect and by a Fgf3/Fgf10-mediated growth stimulation predominantly at the labial aspect (Wang et al., 2007) . Although lower incisors are strongly growth-retarded in Msx1 ;BMP4 tg/tg mice (Fig. 4L) . A likely explanation for the stage-specific difference of the phenotype may be that Pax9 and Msx1 continue to interact in the incisor mesenchyme of adult mice to regulate transcription Fgf3 and Fgf10. Thus, in certain genetic backgrounds the expression levels of Fgf3 and Fgf10 are apparently sufficient for early incisor growth, however, the levels could be insufficient to maintain an epithelial stem cell pool over a long period. Experimental strategies that inactivate Pax9 and Msx1 in adult mice will be required to directly test the involvement of Pax9 and Msx1 in the maintenance of dental stem cell compartments. The first molecular events that establish lower incisor asymmetry are unknown, but may involve cell fate decisions at the bud stage. Notably, at E12.5, Msx1 is expressed in labial side dental epithelium, whereas Msx1 ;Pax9 +/− mutant lower incisors, it will be interesting to determine whether the asymmetric epithelial expression of Msx1 contributes to the asymmetric growth and differentiation of mouse incisors. In addition to abnormal Msx1 expression in incisor epithelium, we found Notch1 to be markedly down-regulated in the dental mesenchyme of Msx1 +/− ;Pax9 +/− mutant incisors at E12.5 and E13.5.
Notch1 is expressed in the dental epithelium of developing molars at the dental lamina and bud stages, and in both dental epithelium and mesenchyme at the cap stage (Mitsiadis et al., 1995) . In the developing mouse incisors, Notch signaling has been implicated in the regulation of epithelial cell fate in the cervical loops (Tummers et al., 2007) . Notch1 seems to be expressed in the incisor mesenchyme earlier than in molar teeth. Interestingly, FGF10 has been shown to stimulate expression of lunatic fringe, a regulator of Notch signaling, and it has been proposed that FGF signaling is linked to cell fate decisions in incisor stem cells (Harada et al., 1999; Mustonen et al., 2002) . Since Notch1 knockout mice die early during mid-gestation (Swiatek et al., 1994) , conditional deletion of Notch1 in the dental mesenchyme will be required to investigate its role in the establishment of epithelial asymmetry in rodent incisors.
Genetic interactions in oligodontia, selective tooth agenesis and orofacial clefting
The causes for the majority of congenital, sporadic forms of missing teeth in humans are unknown, and gene-gene interactions may underlie a significant number of these cases. Based on the large number of studies showing that mutations in PAX9 or MSX1 cause nonsyndromic oligodontia, both genes are promising candidates for an involvement in causative gene-gene interactions. A previous study found that concomitant polymorphisms in MSX1 and PAX9 were overrepresented in a small group of human hypodontia patients (Vieira et al., 2004 (Lin et al., 2009) . It has been suggested that different tissue origins may underlie these different genetic sensitivities. Maxillary incisors arise from the fronto-nasal process and neural crest-derived ectomesenchymal cells that migrate from caudal midbrain and rostral hindbrain, while mandibular incisors arise from the first branchial arch and neural crest-derived ectomesenchymal cells that migrate from the hindbrain (Cobourne and Mitsiadis, 2006) . Specific patterns of homeobox-containing genes indicate that different identities of these cell populations are maintained during odontogenesis (Cobourne and Sharpe, 2003) , and it seems plausible that Pax9 and Msx1 interact differently with distinct tooth-specific genetic programs. Lastly, cleft lip with or without cleft palate (CL/P) and cleft palate only (CPO) are among the most frequent developmental birth defects, with prevalences as high as 1/500 in some populations; studies suggest that more than 50% of cases are not associated with a syndrome (Murray, 2002) . A combination of genetic interactions and environmental factors has been suggested to underlie most sporadic cases, but the identification of genes that play a major role in this multifactorial process is difficult (Jugessur and Murray, 2005; Vieira et al., 2005) . Interestingly, CL/P and CPO are often associated with missing teeth, and recent analyses indicate that the incidence of missing teeth is significantly higher even outside the cleft region and in the mandibular jaw (Shapira et al., 2000; Slayton et al., 2003) . These data suggest that upper lip, secondary palate and teeth share some genetic pathways during their development. In humans, CL/P has been identified in oligodontia patients with heterozygous MSX1 mutations (summarized in Vieira, 2008) . In addition, specific polymorphisms in PAX9 or MSX1 have recently been associated with cleft lip in humans (Ichikawa et al., 2006; Modesto et al., 2006) . CL/P is a relatively rare craniofacial abnormality in mice, but our data show that this phenotype manifests in Pax9 −/− ;Msx1 −/− mouse mutants on a mixed C57BL/6J;CBA/J;CD1 genetic background. However, the incomplete penetrance and variable expressivity (unilateral or bilateral cleft lip) indicate that additional genetic modifiers contribute to cleft lip formation in this digenic mouse model. Pax9/Msx1-deficient mouse models may facilitate the identification of critical genetic modifiers of CL/P and help to elucidate the role of genetic interactions in non-syndromic craniofacial abnormalities.
